IP Library › Granted Patent US 12,569,697
Granted Patent B2
US 12,569,697 · App. 16/469,922 · Granted Mar 10, 2026

Device for the medical treatment of humans and animals, and application device for same

Inventors: Patricia Buchegger (Wiener Neustadt, AT); Dominik Burger (Alteglofsheim, DE); Dariusz Korzec (Falkenstein, DE); Stefan Nettesheim (Regensburg, DE); Christian Rohrer (Villach, AT); Florian Hoppenthaler (Parkstetten, DE); Katharina Merz (Neufahrn, DE)
Assignee: Relyon Plasma GmbH
A61M35/30A61N1/44
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,569,697
App. No.
16/469,922
Granted
Mar 10, 2026
Kind
B2
Abstract

Device for the medical treatment of humans and/or animals, particularly for treating wounds and/or dermatoses, comprising a reactive gas generator designed for generating reactive gases and an application device for applying the reactive gases in a treatment area, comprising a neutralization device designed for neutralizing reactive gases, by means of which the concentration of reactive gases outside the treatment area can be reduced.

Claims (32)

1 . A device comprising:

a reactive gas generator designed for generating reactive gases; and

a patch designed for local treatment of wounds, delimited toward an outside, wherein the patch includes at least one inlet port configured for introducing the reactive gases,

wherein a covering device of the patch is selected from the group consisting of an occlusive film, a distribution film, and combinations thereof,

wherein an open cell foam blended with activated charcoal encircles a fastening edge of the patch and a treatment area to thereby reduce a concentration of the reactive gases outside of the treatment area, and

wherein the treatment area is enclosed by the fastening edge, wherein the open cell foam does not cover the treatment area.

2 . The device of claim 1 , wherein the patch comprises at least one outlet port configured for removing the reactive gases from the treatment area.

3 . The device of claim 2 , wherein the open cell foam blended with activated charcoal is arranged in the treatment area, which covers the outlet port.

4 . The device of claim 1 , wherein the fastening edge of the covering device is fastenable to skin.

5 . The device of claim 4 , wherein the fastening edge comprises an adhesive layer embodied as an adhesive film, and wherein the adhesive layer forms an outer boundary surface of the covering device that faces away from the treatment area.

6 . A treatment kit for fabricating the device of claim 1 , the treatment kit comprising:

the patch and the open cell foam blended with activated charcoal.

7 . The device of claim 1 , wherein the covering device is a covering film, and wherein the covering film is the occlusive film.

8 . The device of claim 7 , wherein the at least one inlet port is connected to an adapter, which is mounted gas-tight onto the occlusive film.

9 . The device of claim 7 , wherein the covering device further comprises a foam, a superabsorber, a fleece, or combinations thereof.

10 . The device of claim 2 , wherein the reactive gases are introducible in the treatment area via the inlet port using a tubular film.

11 . The device of claim 5 , wherein the adhesive layer comprises a gas-permeable material.

12 . The device of claim 1 , wherein the concentration of the reactive gases is regulated by a cell density, a cell size and an effective surface of the open cell foam blended with activated charcoal.

13 . A device comprising:

a reactive gas generator designed for generating reactive gases; and

a patch designed for local treatment of wounds, delimited toward an outside, wherein the patch includes at least one inlet port configured for introducing the reactive gases,

wherein a covering device of the patch is selected from the group consisting of an occlusive film, a distribution film, and combinations thereof,

wherein an open cell foam blended with activated charcoal encircles a fastening edge of the patch and a treatment area, and

wherein the treatment area is enclosed by the fastening edge, wherein the open cell foam does not cover the treatment area.

14 . The device of claim 13 , wherein a concentration of the reactive gases is regulated by a cell density, a cell size and an effective surface of the open cell foam blended with activated charcoal.

15 . A device comprising:

a reactive gas generator designed for generating reactive gases; and

a patch designed for local treatment of wounds, delimited toward an outside, wherein the patch includes at least one inlet port configured for introducing the reactive gases,

wherein a covering device of the patch is selected from the group consisting of an occlusive film, a distribution film, and combinations thereof,

wherein an open cell foam blended with activated charcoal encircles a fastening edge of the patch and a treatment area,

wherein the open cell foam is frame-shaped, and

wherein an inner area of the frame is free of the open cell foam.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 20, 2024
From: LOHMANN & RAUSCHER GMBH
To: RELYON PLASMA GMBH
Reel/Frame 069654/0277 →
Priority Claims (1)
DE 102016014942.6 · Dec 14, 2016 · national
Continuity (1)
Related Publication 20190388666A1 · Dec 26, 2019
References Cited (25)
US 8853486B2 · Wild et al. · 2014 [cited by applicant]
US 9314603B2 · Kummerfeld et al. · 2016 [cited by applicant]
US 9498637B2 · Sanders et al. · 2016 [cited by applicant]
US 10004914B2 · Nettesheim et al. · 2018 [cited by applicant]
US 10143510B2 · Nettesheim et al. · 2018 [cited by applicant]
US 11006995B2 · Stieber et al. · 2021 [cited by applicant]
US 11752040B2 · Grillitsch et al. · 2023 [cited by applicant]
US 20030187412A1 · Martin · 2003 [cited by examiner]
US 20110288458A1 · Jones · 2011 [cited by examiner]
US 20140249495A1 · Mumby · 2014 [cited by examiner]
US 20160287310A1 · Nettesheim · 2016 [cited by examiner]
US 20160296738A1 · Suscheck · 2016 [cited by applicant]
US 20190290496A1 · Brownhill · 2019 [cited by examiner]
US 20190314535A1 · Golkowski · 2019 [cited by examiner]
DE 102008054401A1 · 2010 [cited by applicant]
DE 102009019646A1 · 2010 [cited by applicant]
DE 102011001416A1 · 2012 [cited by applicant]
DE 102012003563A1 · 2013 [cited by applicant]
DE 102013113905A1 · 2015 [cited by applicant]
DE 102013113941A1 · 2015 [cited by applicant]
EP 2636417A1 · 2013 [cited by applicant]
WO WO1998010825 · 1998 [cited by applicant]
WO 2011023478A1 · 2011 [cited by applicant]
WO 2015184395A2 · 2015 [cited by applicant]
International Preliminary Report on Patentability dated Jun. 18, 2019 issued in related PCT/EP2017/077499 (13 pgs). [cited by applicant]